Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.059 | 0.7 |